drugset / Trial / NCT02332733
Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the safety of and immune response to two doses of a dengue vaccine (TV003) given 6 months apart to healthy adults, adolescents, and children in Thailand.
Timeline
- Start
- 2014-11
- Primary completion
- 2018-10-26
- Completion
- 2018-10-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TV003 | Vaccine | 0.5 ml | Subcutaneous |
| Subject | TV003 | Vaccine | 1000 unknown | Subcutaneous |